Myrexis Cmn Stk Performance
| MYRXDelisted Stock | USD 0 0.00 0.00% |
The company secures a Beta (Market Risk) of 3.71, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Myrexis Cmn will likely underperform. Myrexis Cmn Stk right now secures a risk of 0.0%. Please verify Myrexis Cmn Stk jensen alpha, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Myrexis Cmn Stk will be following its current price movements.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Myrexis Cmn Stk has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Myrexis Cmn is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors. ...more
| Total Cashflows From Investing Activities | 71.3 M |
Myrexis |
Myrexis Cmn Relative Risk vs. Return Landscape
If you would invest 0.10 in Myrexis Cmn Stk on September 12, 2024 and sell it today you would earn a total of 0.00 from holding Myrexis Cmn Stk or generate 0.0% return on investment over 90 days. Myrexis Cmn Stk is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of pink sheets are less volatile than Myrexis, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Myrexis Cmn Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Myrexis Cmn's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Myrexis Cmn Stk, and traders can use it to determine the average amount a Myrexis Cmn's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| MYRX |
Based on monthly moving average Myrexis Cmn is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Myrexis Cmn by adding Myrexis Cmn to a well-diversified portfolio.
Myrexis Cmn Fundamentals Growth
Myrexis Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Myrexis Cmn, and Myrexis Cmn fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Myrexis Pink Sheet performance.
| Return On Equity | -0.26 | ||||
| Return On Asset | -0.15 | ||||
| Current Valuation | 3.93 M | ||||
| Shares Outstanding | 34.48 M | ||||
| Price To Earning | (0.10) X | ||||
| Price To Book | 4.42 X | ||||
| EBITDA | (10.8 M) | ||||
| Cash And Equivalents | 1.21 M | ||||
| Cash Per Share | 0.04 X | ||||
| Debt To Equity | (1.51) % | ||||
| Book Value Per Share | 0.03 X | ||||
| Cash Flow From Operations | (12.97 M) | ||||
| Earnings Per Share | (0.39) X | ||||
| Total Asset | 1.24 M | ||||
| Retained Earnings | (128.49 M) | ||||
| Current Asset | 1.24 M | ||||
| Current Liabilities | 74 K | ||||
About Myrexis Cmn Performance
Evaluating Myrexis Cmn's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Myrexis Cmn has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Myrexis Cmn has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Myrexis, Inc. focuses on identifying, evaluating, and making financial investments in life sciences assets. The company was formerly known as Myriad Pharmaceuticals, Inc. and changed its name to Myrexis, Inc. in July 2010. Myrexis operates under Shell Companies classification in the United States and is traded on OTC Exchange. It employs 1 people.Things to note about Myrexis Cmn Stk performance evaluation
Checking the ongoing alerts about Myrexis Cmn for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Myrexis Cmn Stk help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Myrexis Cmn Stk is not yet fully synchronised with the market data | |
| Myrexis Cmn Stk has some characteristics of a very speculative penny stock | |
| Myrexis Cmn Stk has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (11.62 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Myrexis Cmn Stk currently holds about 1.21 M in cash with (12.97 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.04, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
- Analyzing Myrexis Cmn's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Myrexis Cmn's stock is overvalued or undervalued compared to its peers.
- Examining Myrexis Cmn's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Myrexis Cmn's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Myrexis Cmn's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Myrexis Cmn's pink sheet. These opinions can provide insight into Myrexis Cmn's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Consideration for investing in Myrexis Pink Sheet
If you are still planning to invest in Myrexis Cmn Stk check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Myrexis Cmn's history and understand the potential risks before investing.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |